{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:31:53Z","timestamp":1782343913659,"version":"3.54.5"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>HI, a fusion protein that consists of the alpha-toxin (Hla) and the N2 domain of iron surface determinant B (IsdB), is one of the antigens in the previously reported <jats:italic>S. aureus<\/jats:italic> vaccine rFSAV and has already entered phase II clinical trials. Previous studies revealed that HI is highly immunogenic in both mice and healthy volunteers, and the humoral immune response plays key roles in HI-mediated protection. In this study, we further investigated the protective efficacy of immunization with HI plus four different adjuvants in a mouse bacteremia model. Results showed that HI-mediated protection was altered in response to different adjuvants. Using antisera from immunized mice, we identified seven B-cell immunodominant epitopes on Hla and IsdB, including 6 novel epitopes (Hla<jats:sub>1-18<\/jats:sub>, Hla<jats:sub>84-101<\/jats:sub>, Hla<jats:sub>186-203<\/jats:sub>, IsdB<jats:sub>342-359<\/jats:sub>, IsdB<jats:sub>366-383<\/jats:sub>, and IsdB<jats:sub>384-401<\/jats:sub>). The immunodominance of B-cell epitopes, total IgG titers and the levels of IFN-\u03b3 and IL-17A from mice immunized with HI plus different adjuvants were different from each other, which may explain the difference in protective immunity observed in each immunized group. Thus, our results indicate that adjuvants largely affected the immunodominance of epitopes and the protective efficacy of HI, which may guide further adjuvant screening for vaccine development and optimization.<\/jats:p>","DOI":"10.3389\/fimmu.2021.684823","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:30:26Z","timestamp":1622089826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhifu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianli","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/1757913917743881","article-title":"WHO Global Priority Pathogens List on Antibiotic Resistance: An Urgent Need for Action to Integrate One Health Data","volume":"138","author":"Govindaraj Vaithinathan","year":"2018","journal-title":"Perspect Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/21548331.2018.1435128","article-title":"Morbidity, Mortality, and Management of Methicillin-Resistant S. Aureus Bacteremia in the USA: Update on Antibacterial Choices and Understanding","volume":"46","author":"Ortwine","year":"2018","journal-title":"Hosp Practice"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34414","article-title":"Efficacy Profile of a Bivalent Staphylococcus Aureus Glycoconjugated Vaccine in Adults on Hemodialysis: Phase III Randomized Study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.010","article-title":"Safety, Tolerability, and Immunogenicity of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag): Results From a First-in-Human Randomised, Placebo-Controlled Phase 1\/2 Study","volume":"35","author":"Frenck","year":"2017","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.045","article-title":"The Immunogenicity and Safety of Different Formulations of a Novel Staphylococcus Aureus Vaccine (V710): Results of Two Phase I Studies","volume":"30","author":"Harro","year":"2012","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a Polysaccharide Conjugate Vaccine Against S. Aureus Infection: From the Lab Bench to Phase III Clinical Trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine."},{"key":"B8","article-title":"Staphylococcus Aureus Vaccine Preclinical and Clinical Development: Current State of the Art","volume":"41","author":"Redi","year":"2018","journal-title":"New Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010134","article-title":"Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine Against Staphylococcus Aureus Infection in Animal Models","volume":"8","author":"Zeng","year":"2020","journal-title":"Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e81212","DOI":"10.1371\/journal.pone.0081212","article-title":"Evaluation of the Protective Immunity of a Novel Subunit Fusion Vaccine in a Murine Model of Systemic MRSA Infection","volume":"8","author":"Zuo","year":"2013","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/srep15553","article-title":"Protective Efficacy and Mechanism of Passive Immunization With Polyclonal Antibodies in a Sepsis Model of Staphylococcus Aureus Infection","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0165659","DOI":"10.1371\/journal.pone.0165659","article-title":"Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients","volume":"11","author":"Aw-Yong","year":"2016","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa602","article-title":"An Immunodominant Epitope-Specific Monoclonal Antibody Cocktail Improves Survival in a Mouse Model of Staphylococcus Aureus Bacteremia","author":"Zhao","year":"2020","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of Adjuvanticity: A Review on Adjuvants in Licensed Vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of Action of Adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040161","article-title":"Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine","volume":"7","author":"Wang","year":"2019","journal-title":"Vaccines"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pro.579","article-title":"2-Methyl-2,4-pentanediol Induces Spontaneous Assembly of Staphylococcal Alpha-Hemolysin Into Heptameric Pore Structure","volume":"20","author":"Tanaka","year":"2011","journal-title":"Protein Sci: Publ Protein Society"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/bi200369p","article-title":"Unique Heme-Iron Coordination by the Hemoglobin Receptor IsdB of Staphylococcus Aureus","volume":"50","author":"Gaudin","year":"2011","journal-title":"Biochemistry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103945","article-title":"Recombinant PBP2a of Methicillin-Resistant S. Aureus Formulation in Alum and Montanide ISA266 Adjuvants Induced Cellular and Humoral Immune Responses With Protection in Balb\/C Mice","volume":"140","author":"Mortazavi","year":"2020","journal-title":"Microb Pathogeb"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1038\/s41598-018-22044-y","article-title":"Protective Humoral and CD4(+) T Cellular Immune Responses of Staphylococcus Aureus Vaccine MntC in a Murine Peritonitis Model","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte Chemoattractant Protein-1 (MCP-1): An Overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections - United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir846","article-title":"Staphylococcus Aureus Alpha-Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome","volume":"205","author":"Kebaier","year":"2012","journal-title":"J Infect Diseases"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00442-12","article-title":"Abscess Formation and Alpha-Hemolysin Induced Toxicity in a Mouse Model of Staphylococcus Aureus Peritoneal Infection","volume":"80","author":"Rauch","year":"2012","journal-title":"Infection Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02023-14","article-title":"Characterization of Alpha-Toxin Hla Gene Variants, Alpha-Toxin Expression Levels, and Levels of Antibody to Alpha-Toxin in Hemodialysis and Postsurgical Patients With Staphylococcus Aureus Bacteremia","volume":"53","author":"Sharma-Kuinkel","year":"2015","journal-title":"J Clin Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5229-2","article-title":"Safety and Tolerability of a Single Administration of AR-301, A Human Monoclonal Antibody, in ICU Patients With Severe Pneumonia Caused by Staphylococcus Aureus: First-in-Human Trial","volume":"44","author":"Francois","year":"2018","journal-title":"Intensive Care Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12097","article-title":"Iron-Regulated Surface Determinant B (IsdB) Promotes Staphylococcus Aureus Adherence to and Internalization by Non-Phagocytic Human Cells","volume":"15","author":"Zapotoczna","year":"2013","journal-title":"Cell Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine Adjuvants: Understanding the Structure and Mechanism of Adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/mmy\/myu045","article-title":"Adjuvants and Delivery Systems for Antifungal Vaccines: Current State and Future Developments","volume":"53","author":"Portuondo","year":"2015","journal-title":"Med Mycology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.08.003","article-title":"Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools","volume":"17","author":"Mei","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molimm.2018.03.001","article-title":"A Novel Multi-Peptide Subunit Vaccine Admixed With AddaVax Adjuvant Produces Significant Immunogenicity and Protection Against Proteus Mirabilis Urinary Tract Infection in Mice Model","volume":"96","author":"Choubini","year":"2018","journal-title":"Mol Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100402","article-title":"MF59 is a Safe and Potent Vaccine Adjuvant for Flu Vaccines in Humans: What Did We Learn During Its Development","volume":"82","author":"O\u2019Hagan","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.019","article-title":"The STING Activator c-di-AMP Exerts Superior Adjuvant Properties Than the Formulation Poly(I:C)\/Cpg After Subcutaneous Vaccination With Soluble Protein Antigen or DEC-205-mediated Antigen Targeting to Dendritic Cells","volume":"37","author":"Volckmar","year":"2019","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.007","article-title":"LT Adjuvant Modulates Epitope Specificity and Improves the Efficacy of Murine Antibodies Elicited by Sublingual Vaccination With the N-terminal Domain of Streptococcus Mutans P1","volume":"35","author":"Batista","year":"2017","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01175","article-title":"Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein","volume":"8","author":"Maeda","year":"2017","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0022-1759(00)00279-9","article-title":"Effect of IFN-gamma on the Killing of S. Aureus in Human Whole Blood. Assessment of Bacterial Viability by CFU Determination and by a New Method Using Alamarblue","volume":"245","author":"DeForge","year":"2000","journal-title":"J Immunological Methods"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40891","article-title":"Il-17 is Essential for Host Defense Against Cutaneous Staphylococcus Aureus Infection in Mice","volume":"120","author":"Cho","year":"2010","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.684823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:30:29Z","timestamp":1622089829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.684823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2021.684823"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.684823","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"article-number":"684823"}}